An Indian pharmaceutical business called Fortune Healthcare produces the drug Fildena 50mg. The active component of sildenafil citrate, which is responsible for the medication's therapeutic benefits, is in each purple tablet. The mechanism of action of sildenafil citrate involves blocking the enzyme PDE5, which is in charge of breaking down cyclic guanosine monophosphate (cGMP). An erection is made easier by Fildena's ability to inhibit PDE5, which raises cGMP levels and promotes smooth muscle relaxation and increases blood flow to the penile region.
Popular Posts
-
Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with angiotensin II receptor antagonist
-
Pulmonary and Physical Rehabilitation in Critically Ill Patients
-
Finance Minister Announces Rs 1.7 lakh Crore Coronavirus Relief Package
By HCPNews com -
Story of HCP FORUM
-
Hues of Color Afterimages